Have you been diagnosed with Crohn's Disease?
This page is dedicated to the recruitment of participants for a clinical trial treatment for moderately to severely active Crohn’s Disease to be conducted by the University of the Sunshine Coast (QLD).
Full title: A Phase III, randomized, double blind, placebo-controlled, multi-centre study to evaluate the efficacy and safety of etrolizumab as an induction and maintenance treatment for patients with moderately to severely active Crohn’s Disease.
You are invited to take part in this research project. This is because you have been diagnosed with Crohn’s Disease.
The research project is testing the safety and effectiveness of a potential new treatment for patients with moderately to severely active Crohn’s Disease. Please complete the following survey to express interest in participating in the above-mentioned trial.
Please be aware that completion of the survey does not guarantee entry into the trial.
Ethics approval – Bellberry Limited
If you experience difficulty completing the survey please email email@example.com or call 07 5456 3797.